2m 2m 2m 2m 2m 2m 2m
ATEA PHARMA (AVIR)
NASDAQ
$5.47+$0.04 (+0.64%)
Price as of Aug 21, 2026 7:30 PM EDT- $435.5MMarket Cap
- 48.36%1-Year Change
- BiotechnologyIndustry
ATEA PHARMA (AVIR)
$5.47+$0.04 (+0.64%)
AVIR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $5.43 | ||
Change | +$0.07 (+1.31%) | ||
Open | $5.40 | ||
High | $5.64 | ||
Low | $5.31 | ||
Previous Close | $5.36 | ||
Volume | 209,893 | ||
30-Day Average Volume | 364,440 | ||
1-Week Change | 6.05% | ||
1-Month Change | 11.50% | ||
1-Year Change | 48.36% | ||
3-Year Change | 60.65% | ||
5-Year Change | -81.69% | ||
Fundamentals | |||
Shares Outstanding | 80.2M | ||
Total Assets | $232.3M | ||
Market Cap | $435.5M | ||
Enterprise Value | $359.0M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$32.9M | ||
Free Cash Flow | -$37.1M | ||
EBIT | -$32.9M | ||
EBITDA | -$32.8M | ||
Net Working Capital | $200.5M | ||
EPS | -$0.41 | ||
Enterprise Value/EBITDA | -11 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -13 | ||
PEG | -0 | ||
Price/Free Cash Flow | -12 | ||
Price/Operating Cash Flow | -12 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 11 | ||
Last Split Date | 02/14/2018 | ||
Earnings & Revenue